Why a popular anti-ageing amino acid may be a sign of the body fighting inflammation rather than a missing nutrient, what a four-month mouse experiment showed, and how far this is from proof in people.
On 23 October 2026 Cell published a study from the Yale School of Medicine, led by immunologist Vishwa Deep Dixit, that runs against a well-known idea about taurine. In 2023 a paper in Science reported that blood taurine falls with age in mice, monkeys and people, and that restoring it extended healthy life and lifespan in mice. The Yale team compared blood serum from younger adults, aged 20 to 40, with older adults, aged 60 to 99, and found the reverse: taurine was higher in the older group. The press release does not say how many people were compared. Old mice showed the same pattern.
The authors read this not as a deficit but as a response. Their working idea is that the body raises taurine with age in a failed attempt to hold back chronic low-grade inflammation, the process researchers call inflammaging.
A brake inside immune cells
Most of the study is about macrophages, the immune cells that sense trouble first. When they meet danger signals such as bacterial toxins, a protein complex called the NLRP3 inflammasome assembles inside them and switches on inflammation. Overactive NLRP3 has been linked to inflammaging in earlier work.
In cell culture, macrophages released up to 80% of their taurine as these complexes were forming. Putting taurine back into the cells stopped the inflammatory response that follows; at the molecular level it prevented NLRP3 from breaking apart the trans-Golgi network, a step the complex needs to activate. When the researchers lowered taurine in macrophages instead, NLRP3-driven inflammation sped up, even in young mice. In Dixit's words, taurine is "one of the brakes within the cells that is keeping the inflammasome in check".
What extra taurine did in old mice
Male mice aged 20 months received taurine in their drinking water for four months, with about 15 animals per group in the functional tests. Blood taurine doubled. After three months the treated mice handled glucose better, stayed longer on a rotating rod, a test of balance and coordination, and had a stronger grip. They lost body weight and fat mass but not lean mass. The authors describe these as signs of a longer healthspan.
The study did not measure how long the mice lived. A separate experiment used young adult mice: those given taurine for five days before a lethal dose of a bacterial toxin died significantly less often than untreated mice. That is a model of acute inflammation, not of ageing.
A clue from calorie restriction in people
The project started with CALERIE-II, a trial in which healthy adults ate less for a year; on average they cut calorie intake by about 14%. In fat tissue taken from under the skin of a subset of participants, taurine and its precursor hypotaurine rose after a year of restriction, and several genes of the inflammasome pathway were less active. Blood plasma levels did not change. This is an observation inside a diet trial, not a trial of taurine.
Where this leaves the supplement
Three research groups now disagree about the basic fact. The 2023 Science paper found taurine falling with age. A 2025 Science paper from the US National Institute on Aging found it rising or unchanged in three human cohorts, as well as in monkeys and mice, and concluded that a fall in taurine is not a universal feature of ageing. The Yale group finds it higher in older people. For now, a blood taurine level is not a reliable gauge of how fast someone is ageing.
The new work also does not show that taurine slows ageing in people. Its evidence comes from cells, a four-month experiment in old male mice without a lifespan measurement, and a one-time comparison of younger and older adults. The human data on calorie restriction come from fat tissue, not from taking taurine.
The two registered human trials we found are small. One, NCT05149716, enrolled 24 women and finished in 2020; another, NCT06613542, enrolled 90 men and women aged 55 to 75 for six months, with biological age and physical fitness among its outcomes, and finished in November 2025. Neither has posted results on ClinicalTrials.gov.
Dixit's team is now studying what happens to taurine after it leaves macrophages and whether the findings could translate into something that helps older adults. The work was funded by the US National Institutes of Health, Yale University, the American Federation for Aging Research and the Glenn Foundation for Medical Research; the authors declared no competing interests. Anyone considering taurine for ageing should discuss it with a doctor.
Sources
Guan C, et al. Taurine lowers inflammaging by regulating the NLRP3 inflammasome in macrophages. Cell, 23 October 2026. PubMed 42914977
Yale School of Medicine. Study reveals amino acid can diminish age-related inflammation, 23 October 2026
Singh P, et al. Taurine deficiency as a driver of aging. Science, 2023. PubMed 37289866
Fernandez ME, et al. Is taurine an aging biomarker? Science, 2025. PubMed 40472098
ClinicalTrials.gov: NCT05149716, NCT06613542
Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.
Read next
ResearchMedicine and treatmentHormone replacement for absent parathyroids held up over 3.5 years
For adults with hypoparathyroidism who live on calcium and vitamin D tablets: what the longest follow-up of this daily hormone replacement found, and where the evidence still stops.
ResearchBiomarkersAn eye photo predicts death risk almost as well as age
For anyone curious about AI tests of biological age: what a new retinal model adds to the oldest risk factor of all, which causes of death it reads best, and what it still cannot tell one person.
ResearchMedicine and treatmentKnees, cholesterol and an AI ECG: what four new trials showed
4 stories this week: knee osteoarthritis with obesity, a cholesterol-lowering strategy in artery disease, AI screening for heart rhythm problems and clots around arm catheters. Four randomised trials, each with what it does not yet show.
Digest · 4 stories
